MBC-Parkville houses researchers of the Florey Institute of Neuroscience and Mental Health and the University of Melbourne, Austin Health and Melbourne Health. MBC-Parkville is home to the laboratory research activities of the MBC. Here, our neuroscientists engage in biomarker discovery and characterisation. New research findings form the basis for future translational studies, with potential use in the clinic. MBC-Parkville is also a key imaging centre, housing some of the world’s most advanced research-dedicated imaging PET/CT scanners which will fast track the development of novel treatments for brain disorders such as dementia, epilepsy, mental illness, Alzheimer’s and Parkinson’s disease.
MBC-Parkville West (155 Oak St) is a key site for the national and international multi-centre studies such as the Australian Imaging, Biomarkers and Lifestyle Study of Ageing (AIBL), and the Dominantly Inherited Alzheimer’s Network (DIAN)
MBC Austin (Heidelberg)
MBC-Austin houses researchers of The University of Melbourne, researchers of the Florey Institute of Neuroscience and Mental Health and the Austin Hospital (Austin Health). MBC-Austin is a key clinical trial site, investigating a spectrum of common brain diseases, including Epilepsy and Stroke and other neurodegenerative conditions.
MBC-RMH houses researchers of the Florey Institute of Neuroscience and Mental Health, the University of Melbourne and the Royal Melbourne Hospital (Melbourne Health). RMH is the largest and most dynamic research hospital in Australia.
MBC-RMH is a NHMRC Centre for Research Excellence in Translation Neuroscience and leads major national and international clinical trials investigating therapies for common brain diseases including stroke, epilepsy and MS. At MBC-RMH, clinical practice and neuroscience research converge to provide a transformative platform for the development and trial of new therapies and subsequent improvement in clinical practice guidelines for common brain diseases.